Lysergic Acid Diethylamide (LSD)
Clark & Bliss (1957). Psychopharmacological studies of lysergic acid diethylamide (LSD-25) intoxication: Effects of premedication with BOL-128 (2-Bromo-d-ly-sergic acid diethylamide), mescaline, atropine, amobarbital, and chlorpromazine). A.M.A. Archives of Neurology and Psychiatry.
Abramson et al. (1958). Lysergic acid diethylamide (LSD-25) antagonists: II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide). A.M.A. Archives of Neurology and Psychiatry.
Larson et al. (1981). Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei. The Journal of Pharmacology and Experimental Therapeutics.
Kanel et al. (1998). Automated extraction of lysergic acid diethylamide (LSD) and N-demethyl-LSD from blood, serum, plasma, and urine samples using the Zymark RapidTrace with LC/MS/MS confirmation. Journal of Forensic Sciences.
Canezin et al. (2001). Determination of LSD and its metabolites in human biological fluids by high-performance liquid chromatography with electrospray tandem mass spectrometry. Journal of Chromatography.
Dyer et al. (2002). NHS settles claim of patients treated with LSD. BMJ.
Fang, Liu & Lin (2002). Determination of lysergic acid diethylamide (LSD) by application of online 77 K fluorescence spectroscopy and a sweeping technique in micellar electrokinetic chromatography. Talanta.
Grobosch & Lemm-Ahlers (2002). Immunoassay screening of lysergic acid diethylamide (LSD) and its confirmation by HPLC and fluorescence detection following LSD ImmunElute extraction. Journal of Analytical Toxicology.
Klette et al. (2002). LC-mS analysis of human urine specimens for 2-oxo-3-hydroxy LSD: method validation for potential interferants and stability study of 2-oxo-3-hydroxy LSD under various storage conditions. Journal of Analytical Toxicology.
Nichols et al. (2002). Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD). Journal of Medicinal Chemistry.
Skopp et al. (2002). Short-term stability of lysergic acid diethylamide (LSD), N-desmethyl-LSD, and 2-oxo-3-hydroxy-LSD in urine, assessed by liquid chromatography-tandem mass spectrometry. Clinical Chemistry.
Snelders & Kaplan (2002). LSD therapy in Dutch psychiatry: changing socio-political settings and medical sets. Medical History.
Burnley & George (2003). The development and application of a gas chromatography-mass spectrometric (GC-MS) assay to determine the presence of 2-oxo-3-hydroxy-LSD in urine. Journal of Analytical Toxicology.
Fang et al. (2003). Determination of lysergic acid diethylamide (LSD) in mouse blood by capillary electrophoresis/ fluorescence spectroscopy with sweeping techniques in micellar electrokinetic chromatography. Electrophoresis.
Fang, Liu & Lin (2003). On-line identification of lysergic acid diethylamide (LSD) in tablets using a combination of a sweeping technique and micellar electrokinetic chromatography/77 K fluorescence spectroscopy. Electrophoresis.
Libong, Bouchonnet & Ricordel (2003). A selective and sensitive method for quantitation of lysergic acid diethylamide (LSD) in whole blood by gas chromatography-ion trap tandem mass spectrometry. Journal of Analytical Toxicology.